Yujie Kong

TL;DR: Among patients with severe or life-threatening COVID-19, convalescent plasma therapy added to standard treatment, compared with standard treatment alone, did not result in a statistically significant improvement in time to clinical improvement within 28 days.

TL;DR: The successful treatment of this 100-year-old patient using convalescent plasma suggests that it should be added in the management of the elderly, and significant improvement was observed on laboratory indicators and clinical symptoms of the patient.

TL;DR: This study investigated whether interleukin (IL)‐2 or IL‐2/anti‐IL‐2 complexes (IL-2c), which are mediators of Treg expansion, can modulate the severity of antibody‐mediated TRALI in vivo.

TL;DR: An integrated metabonomic-proteomic method was employed to systematically analyze the profiles of metabolites and proteins in an ischemic-hypoxic rat model and found that changes in the levels of metabolites matched the changes in protein abundance within the same pathway.

TL;DR: In China, unnecessary RBCs transfusion was common and may exacerbate the current pressure on blood supplies and Clinicians in certain geographical regions, LOH-2, and operative departments should be targeted with training in transfusion medicine.